Maraviroc Immune Recovery Study, A Multicenter, Randomized, Placebo-Controlled, Exploratory Mechanistic Study Into the Role of Maraviroc on Immune Recovery.
Latest Information Update: 09 Nov 2021
Price :
$35 *
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms MIRS
- 06 Mar 2013 Primary endpoint 'CD4+-cell-count' has not been met.
- 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 06 Mar 2013 Status changed from active, no longer recruiting to completed.